For decades, cumbersome CPAP machines have been the primary way to help people with sleep apnea. A range of new options has recently come into focus.

Incannex Healthcare Inc. (NASDAQ:IXHL) on Thursday detailed an updated clinical development plan for IHL-42X, its oral ...

Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an ...

A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% ...

Snoring is something families joke about; children make inside jokes about the loud sleeper in the house and spouses complain ...

Researchers say a medication originally used for epilepsy may significantly reduce breathing interruptions in people with sleep apnea, raising the possibility of a pill-based treatment.

Snoring is not a rare problem. In fact, according to the American Association of Oral and Maxillofacial Surgeons, right around half of Americans snore. Snoring can be frustrating and even though there ...

Add Yahoo as a preferred source to see more of our stories on Google. If you have obstructive sleep apnea (OSA)—a condition that causes a partial or complete collapse of your upper airway while ...

A nerve stimulator implant called Inspire is helping some sleep apnea patients breathe normally at night when a CPAP machine is not an effective treatment.

Adequate sleep (about seven to eight hours for adults) is crucial to your health, alertness and more. Obstructive sleep apnea ...

Incannex shares drop after announcing a $10 million stock offering to fund its IHL-42X sleep apnea study following positive ...

Researchers found that the medication sulthiame reduced breathing interruptions and improved oxygen levels overnight in people with moderate to severe sleep apnea. The findings were published recently ...